Panel Intelligence expands patient focused market research service

Panel Intelligence, LLC, is pleased to announce expanded capabilities for patient focused market research. For 10 years, Panel Intelligence has provided actionable market intelligence in the form of primary research from clinicians and other healthcare professionals. Panel Intelligence has now significantly expanded its access to patient populations in oncology. This research service provides cancer therapeutics companies with direct access to the ultimate end users of their products and allows them to hear the "voice of the patient."

The range of indications for which Panel Intelligence can now provide patient-based market research includes solid tumor cancers (bladder, breast, colorectal, lung, melanoma, ovarian, prostate, and uterine among others), as well as blood cancers including Hodgkin's and Non-Hodgkin's lymphoma, leukemia (adult ALL, AML, and CML). With this access, Panel Intelligence can recruit statistically robust samples in the cancer types constituting 80% of all cancer illnesses.

With these enhanced patient research capabilities, Panel Intelligence can target patients with defined clinical conditions and parameters to allow segmentation into specific subpopulations by clinical and demographic data. Panel Intelligence accesses a database that includes a profile of each patient and specifically defines their treatment history. As a result, our clients can obtain market research from the specific patient population they are targeting. This service enables clients to evaluate patient education materials, understand compliance issues, and determine unmet needs.

"We are now confident in saying that for almost any patient-focused qualitative or quantitative market research assignment, including tracking surveys and ongoing patient panels, Panel Intelligence can deliver fast, highly targeted, and reliable research reflecting the voice of the patient. We have executed many such assignments and are excited to provide an additional value added service to the life science industry," said Janet Bernard, Vice President for Community at Panel Intelligence.